<DOC>
	<DOCNO>NCT02665494</DOCNO>
	<brief_summary>Multi-centric , observational , prospective study , design pt diagnosis all-stages cholangiocarcinoma , include rare crossing-over histological type , exclude gallbladder cancer ampullary carcinoma .</brief_summary>
	<brief_title>Biliary Cancer Italy : Study Cholangiocarcinoma cAUSEs Risk Factors</brief_title>
	<detailed_description>Patients undergo basal blood sample exams regard blood cell count , renal liver function , tumor marker , inflammatory metabolic state , along screening ( , need , in-depth laboratory analysis ) viral hepatitis infection . Information collect radiological , clinical pathological feature neoplasm time diagnosis , well , late time , natural history . A two-step data analysis perform : Task-1 analysis define risk factor landscape , Task-2 analysis examine influence etiology clinical outcome . Anonymized data store central database , keep Leading Centre .</detailed_description>
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<criteria>voluntary , write , date sign informed consent ; age â‰¥ 18 year ; histologically document diagnosis cholangiocarcinoma ( include histological variant mixed form ) . Neoplasms investigation include gallbladder cancer ampullary carcinoma . Dementia alter mental status lead inability understand render inform consent . Patients already underwent systemic treatment ( chemotherapy and/or target therapy ) may enrol subject data collection BICAUSE Study Protocol Version 1.0 Oct 18th , 2015 10 blood laboratory test ( exception viral screen ) natural history , factor data analysis prognostic factor . Performance status , life expectancy , tumour staging , tumour site ( distal hilar extrahepatic , intrahepatic ) , previous surgical resection , previous biliary stenting , previous radiotherapy part inclusion/exclusion criterion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>